Articles written by: James Jordan

Comparison of CorEnergy Infrastructure Trust Inc. (CORR) and Clough Global Dividend and Income Fund (NYSEAMERICAN:GLV)

This is therefore a contrasting of the profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation in CorEnergy Infrastructure Trust Inc. (NYSE:CORR) and Clough Global Dividend and Income Fund (NYSEAMERICAN:GLV). The two are both Asset Management companies that compete with one another. Valuation & Earnings Gross Revenue Price/Sales Ratio […]

Reviewing Team Inc. (TISI)’s and MAXIMUS Inc. (NYSE:MMS)’s results

We will be contrasting the differences between Team Inc. (NYSE:TISI) and MAXIMUS Inc. (NYSE:MMS) as far as profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership are concerned. The two businesses are rivals in the Business Services industry. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Comparing of ChemoCentryx Inc. (CCXI) and Dynavax Technologies Corporation (NASDAQ:DVAX)

ChemoCentryx Inc. (NASDAQ:CCXI) and Dynavax Technologies Corporation (NASDAQ:DVAX) compete with each other in the Biotechnology sector. We will analyze and compare their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ChemoCentryx Inc. 89.84M 6.23 […]

SPS Commerce Inc. (SPSC) and ePlus inc. (NASDAQ:PLUS) Comparing side by side

SPS Commerce Inc. (NASDAQ:SPSC) and ePlus inc. (NASDAQ:PLUS) are two firms in the Application Software that compete against each other. Below is a comparison of their dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Aratana Therapeutics Inc. (PETX)’s Financial Results Comparing With Liquidia Technologies Inc. (NASDAQ:LQDA)

This is therefore a comparing of the analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation in Aratana Therapeutics Inc. (NASDAQ:PETX) and Liquidia Technologies Inc. (NASDAQ:LQDA). The two are both Biotechnology companies that compete with one another. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Zomedica Pharmaceuticals Corp. (ZOM) and Evoke Pharma Inc. (NASDAQ:EVOK) Comparing side by side

Zomedica Pharmaceuticals Corp. (NYSEAMERICAN:ZOM) and Evoke Pharma Inc. (NASDAQ:EVOK), are influenced by contrast since they are both players in the Drugs – Generic. These factors are particularly influence the analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation of the two firms. Valuation and Earnings Gross Revenue Price/Sales Ratio […]

Reviewing Cyclacel Pharmaceuticals Inc. (CYCC)’s and RedHill Biopharma Ltd. (NASDAQ:RDHL)’s results

Both Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) and RedHill Biopharma Ltd. (NASDAQ:RDHL) are Biotechnology companies, competing one another. We will compare their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cyclacel Pharmaceuticals Inc. N/A 0.00 7.51M […]

Reviewing ChemoCentryx Inc. (CCXI)’s and Amgen Inc. (NASDAQ:AMGN)’s results

ChemoCentryx Inc. (NASDAQ:CCXI) and Amgen Inc. (NASDAQ:AMGN) compete against each other in the Biotechnology sector. We will compare them and contrast their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ChemoCentryx Inc. 89.84M 6.23 […]

Reviewing Menlo Therapeutics Inc. (MNLO)’s and Aileron Therapeutics Inc. (NASDAQ:ALRN)’s results

Menlo Therapeutics Inc. (NASDAQ:MNLO) and Aileron Therapeutics Inc. (NASDAQ:ALRN) compete against each other in the Biotechnology sector. We will compare them and contrast their institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Menlo Therapeutics […]

Advaxis Inc. (ADXS)’s Financial Results Comparing With SELLAS Life Sciences Group Inc. (NASDAQ:SLS)

We are comparing Advaxis Inc. (NASDAQ:ADXS) and SELLAS Life Sciences Group Inc. (NASDAQ:SLS) on their analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation. They both are Biotechnology companies, competing one another. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Advaxis Inc. 6.06M […]